A systematic review and meta-analysis of 271 PCDH19-variant individuals identifies psychiatric comorbidities, and association of seizure onset and disease severity

Kristy L Kolc, Lynette G Sadleir, Ingrid E Scheffer, Atma Ivancevic, Rachel Roberts, Duyen H Pham, Jozef Gecz, Kristy L Kolc, Lynette G Sadleir, Ingrid E Scheffer, Atma Ivancevic, Rachel Roberts, Duyen H Pham, Jozef Gecz

Abstract

Epilepsy and Mental Retardation Limited to Females (EFMR) is an infantile onset disorder characterized by clusters of seizures. EFMR is due to mutations in the X-chromosome gene PCDH19, and is underpinned by cellular mosaicism due to X-chromosome inactivation in females or somatic mutation in males. This review characterizes the neuropsychiatric profile of this disorder and examines the association of clinical and molecular factors with neuropsychiatric outcomes. Data were extracted from 38 peer-reviewed original articles including 271 individual cases. We found that seizure onset ≤12 months was significantly associated (p = 4.127 × 10-7) with more severe intellectual disability, compared with onset >12 months. We identified two recurrent variants p.Asn340Ser and p.Tyr366Leufs*10 occurring in 25 (20 unrelated) and 30 (11 unrelated) cases, respectively. PCDH19 mutations were associated with psychiatric comorbidities in approximately 60% of females, 80% of affected mosaic males, and reported in nine hemizygous males. Hyperactive, autistic, and obsessive-compulsive features were most frequently reported. There were no genotype-phenotype associations in the individuals with recurrent variants or the group overall. Age at seizure onset can be used to provide more informative prognostic counseling.

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Lollipop plot illustrating all the reviewed PCDH19-GCE variants (n = 271). Lollipop size is exponentially proportional to the number of times the variant has been observed. Recurrent (i.e., seen more than once in unrelated individuals) variants are located above the protein and labeled if they occur more than twice
Fig. 2
Fig. 2
Genotype–phenotype association. a Circos plot illustrating the variable cognitive profile of PCDH19-GCE (n = 155) against age at seizure onset: ≤12 months (n = 124) and >12 months (n = 48). Recurrent variants p.Asn340Ser (n = 17) and p.Tyr366Leufs*10 (n = 23) are highlighted in red and blue, respectively. Axes show the number of individuals in each category. Illustration represents cases where relevant information was available. b Bar graph (±1 SEM) illustrating the association of age at seizure onset and ID severity (values from unadjusted linear model), ***p = 3.090 × 10−7. Cognitive function was scored on a scale: (0) “normal”, (1) “borderline”, (2), “mild ID”, (3) “moderate ID”, and (4) “severe/profound ID”, with higher scores indicating increased ID severity. Mean ID severity was derived by totaling the scores and dividing by the number of individuals in that group

References

    1. Juberg RC, Hellman CD. A new familial form of convulsive disorder and mental retardation limited to females. J Pediatr. 1971;79:726–32. doi: 10.1016/S0022-3476(71)80382-7.
    1. Dibbens LM, Tarpey PS, Hynes K, Bayly MA, Scheffer IE, Smith R, et al. X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat Genet. 2008;40:776–81. doi: 10.1038/ng.149.
    1. Scheffer IE, Turner SJ, Dibbens LM, Bayly MA, Friend K, Hodgson B, et al. Epilepsy and mental retardation limited to females: an under-recognized disorder. Brain. 2008;131:918–27. doi: 10.1093/brain/awm338.
    1. Depienne C, Bouteiller D, Keren B, Cheuret E, Poirier K, Trouillard O, et al. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females. PLoS Genet. 2009;5:e1000381. doi: 10.1371/journal.pgen.1000381.
    1. Terracciano Alessandra, Trivisano Marina, Cusmai Raffaella, De Palma Luca, Fusco Lucia, Compagnucci Claudia, Bertini Enrico, Vigevano Federico, Specchio Nicola. PCDH19-related epilepsy in two mosaic male patients. Epilepsia. 2016;57(3):e51–e55. doi: 10.1111/epi.13295.
    1. Thiffault I, Farrow E, Smith L, Lowry J, Zellmer L, Black B, et al. PCDH19‐related epileptic encephalopathy in a male mosaic for a truncating variant. Am J Med Genet A. 2016;170:1585–9. doi: 10.1002/ajmg.a.37617.
    1. Sadleir LG, Gecz J, Scheffer IE. Epilepsies that occur predominantly in girls. In: Johnston MV, Adams HP, Fatemi A, editors. Neurobiology of disease. New York: Oxford University Press; 2016. pp. 307–11.
    1. Marini C, Mei D, Parmeggiani L, Norci V, Calado E, Ferrari A, et al. Protocadherin 19 mutations in girls with infantile-onset epilepsy. Neurology. 2010;75:646–53. doi: 10.1212/WNL.0b013e3181ed9e67.
    1. Specchio N, Marini C, Terracciano A, Mei D, Trivisano M, Sicca F, et al. Spectrum of phenotypes in female patients with epilepsy due to protocadherin 19 mutations. Epilepsia. 2011;52:1251–7. doi: 10.1111/j.1528-1167.2011.03063.x.
    1. Depienne C, Trouillard O, Bouteiller D, Gourfinkel‐ AnI, Poirier K, Rivier F, et al. Mutations and deletions in PCDH19 account for various familial or isolated epilepsies in females. Hum Mutat. 2011;32:E1959–E1975. doi: 10.1002/humu.21373.
    1. Dibbens LM, Kneen R, Bayly M, Heron S, Arsov T, Damiano J, et al. Recurrence risk of epilepsy and mental retardation in females due to parental mosaicism of PCDH19 mutations. Neurology. 2011;76:1514–9. doi: 10.1212/WNL.0b013e318217e7b6.
    1. Dimova PS, Kirov A, Todorova A, Todorov T, Mitev V. A novel PCDH19 mutation inherited from an unaffected mother. Pediatr Neurol. 2012;46:397–400. doi: 10.1016/j.pediatrneurol.2012.03.004.
    1. Duszyc K, Terczynska I, Hoffman-Zacharska D. Epilepsy and mental retardation restricted to females: X-linked epileptic infantile encephalopathy of unusual inheritance. J Appl Genet. 2015;56:49–56. doi: 10.1007/s13353-014-0243-8.
    1. Breuillard D, Leunen D, Chemaly N, Auclair L, Pinard JM, Kaminska A, et al. Autism spectrum disorder phenotype and intellectual disability in females with epilepsy and PCDH-19 mutations. Epilepsy Behav. 2016;60:75–80. doi: 10.1016/j.yebeh.2016.04.009.
    1. Gagliardi M, Annesi G, Sesta M, Tarantino P, Conti P, Labate A, et al. PCDH19 mutations in female patients from Southern Italy. Seizure. 2015;24:118–20. doi: 10.1016/j.seizure.2014.08.010.
    1. Van Harssel J, Weckhuysen S, van Kempen M, Hardies K, Verbeek N, de Kovel C, et al. Clinical and genetic aspects of PCDH19-related epilepsy syndromes and the possible role of PCDH19 mutations in males with autism spectrum disorders. Neurogenetics. 2013;14:23–34. doi: 10.1007/s10048-013-0353-1.
    1. de Lange I, Rump P, Neuteboom R, Augustijn P, Hodges K, Kistemaker A, et al. Male patients affected by mosaic PCDH19 mutations: five new cases. Neurogenetics. 2017;18:147–53. doi: 10.1007/s10048-017-0517-5.
    1. Rhemtulla M, Brosseau-Liard PEacute, Savalei V. When can categorical variables be treated as continuous? A comparison of robust continuous and categorical SEM estimation methods under suboptimal conditions. Psychol Methods. 2012;17:354. doi: 10.1037/a0029315.
    1. O’Connor CM, Ryan CA, Boylan GB, Murray DM. The ability of early serial developmental assessment to predict outcome at 5years following neonatal hypoxic-ischaemic encephalopathy. Early Hum Dev. 2017;110:1–8. doi: 10.1016/j.earlhumdev.2017.04.006.
    1. Hogg RV, Tanis EA, Zimmerman DL. Probability and statistical inference. 9th edition. Pearson Education. Boston, USA. 2015.
    1. Kahr I, Vandepoele K, Van Roy F. Delta-protocadherins in health and disease. Progr Mol Biol Transl Sci. 2013;116:169–92. doi: 10.1016/B978-0-12-394311-8.00008-X.
    1. Depienne C, Leguern E. PCDH19‐related infantile epileptic encephalopathy: an unusual X‐linked inheritance disorder. Hum Mutat. 2012;33:627–34. doi: 10.1002/humu.22029.
    1. Terracciano A, Specchio N, Darra F, Sferra A, Dalla Bernardina B, Vigevano F, et al. Somatic mosaicism of PCDH19 mutation in a family with low-penetrance EFMR. Neurogenetics. 2012;13:341–5. doi: 10.1007/s10048-012-0342-9.
    1. Liu A, Xu X, Yang X, Jiang Y, Yang Z, Liu X, et al. The clinical spectrum of female epilepsy patients with PCDH19 mutations in a Chinese population. Clin Genet. 2017;91:54–62. doi: 10.1111/cge.12846.
    1. Brunklaus A, Ellis R, Reavey E, Forbes G, Zuberi S. Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome. Brain. 2012;135:2329–36. doi: 10.1093/brain/aws151.
    1. Perez D, Hsieh DT, Rohena L. Somatic mosaicism of PCDH19 in a male with early infantile epileptic encephalopathy and review of the literature. Am J Med Genet A. 2017;173:1625–30. doi: 10.1002/ajmg.a.38233.
    1. Ryan SG, Chance PF, Zou CH, Spinner NB, Golden JA, Smietana S. Epilepsy and mental retardation limited to females: an X-linked dominant disorder with male sparing. Nat Genet. 1997;17:92–95. doi: 10.1038/ng0997-92.
    1. Piton A, Gauthier J, Hamdan F, Lafreniere R, Yang Y, Henrion E, et al. Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia. Mol Psychiatry. 2011;16:867–80. doi: 10.1038/mp.2010.54.
    1. Tarpey PS, Smith R, Pleasance E, Whibley A, Edkins S, Hardy C, et al. A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. Nat Genet. 2009;41:535–43. doi: 10.1038/ng.367.
    1. Chugani HT, Phelps ME. Maturational changes in cerebral function in infants determined by FDG positron emission tomography. Science. 1986;231:840–4. doi: 10.1126/science.3945811.
    1. Rice D, Barone S., Jr Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect. 2000;108(Suppl 3):511. doi: 10.1289/ehp.00108s3511.
    1. Gale CR, O’Callaghan FJ, Godfrey KM, Law CM, Martyn CN. Critical periods of brain growth and cognitive function in children. Brain. 2004;127:321–9. doi: 10.1093/brain/awh034.
    1. Chugani HT. A critical period of brain development: studies of cerebral glucose utilization with PET. Prev Med. 1998;27:184–8. doi: 10.1006/pmed.1998.0274.
    1. Knickmeyer RC, Gouttard S, Kang C, Evans D, Wilber K, Smith JK, et al. A structural MRI study of human brain development from birth to 2 years. J Neurosci. 2008;28:12176–82. doi: 10.1523/JNEUROSCI.3479-08.2008.
    1. Gilmore JH, Lin W, Prastawa MW, Looney CB, Vetsa YSK, Knickmeyer RC, et al. Regional gray matter growth, sexual dimorphism, and cerebral asymmetry in the neonatal brain. J Neurosci. 2007;27:1255–60. doi: 10.1523/JNEUROSCI.3339-06.2007.
    1. Glantz LA, Gilmore JH, Hamer RM, Lieberman JA, Jarskog LF. Synaptophysin and postsynaptic density protein 95 in the human prefrontal cortex from mid-gestation into early adulthood. Neuroscience. 2007;149:582–91. doi: 10.1016/j.neuroscience.2007.06.036.
    1. Chayer C, Freedman M. Frontal lobe functions. Curr Neurol Neurosci Rep. 2001;1:547–52. doi: 10.1007/s11910-001-0060-4.
    1. Lagae L, Brambilla I, Mingorance A, Gibson E, Battersby A. Quality of life and comorbidities associated with Dravet syndrome severity: a multinational cohort survey. Dev Med Child Neurol. 2017;60:63–72. doi: 10.1111/dmcn.13591.
    1. Cetica V, Chiari S, Mei D, Parrini E, Grisotto L, Marini C, et al. Clinical and genetic factors predicting Dravet syndrome in infants with SCN1A mutations. Neurology. 2017;88:1037–44. doi: 10.1212/WNL.0000000000003716.
    1. Sadleir LG, Mountier EI, Gill D, Davis S, Joshi C, Devile C, et al. Not all epileptic encephalopathies are Dravet syndrome early profound Thr226Met phenotype. Neurology. 2017;89:1035–42. doi: 10.1212/WNL.0000000000004331.
    1. McIntosh AM, McMahon J, Dibbens LM, Iona X, Mulley JC, Scheffer IE, et al. Effects of vaccination on onset and outcome of Dravet syndrome: a retrospective study. Lancet Neurol. 2010;9:592–8. doi: 10.1016/S1474-4422(10)70107-1.
    1. Pham DH, Tan CC, Homan CC, Kolc KL, Corbett MA, McAninch D, et al. Protocadherin 19 (PCDH19) interacts with paraspeckle protein NONO to co-regulate gene expression with estrogen receptor alpha (ERα) Hum Mol Genet. 2017;26:2042–52. doi: 10.1093/hmg/ddx094.
    1. Tan C, Shard C, Ranieri E, Hynes K, Pham DH, Leach D, et al. Mutations of protocadherin 19 in female epilepsy (PCDH19-FE) lead to allopregnanolone deficiency. Hum Mol Genet. 2015;24:5250–9. doi: 10.1093/hmg/ddv245.
    1. Pederick DT, Richards KL, Piltz SG, Kumar R, Mincheva-Tasheva S, Mandelstam SA, et al. Abnormal cell sorting underlies the unique X-linked inheritance of PCDH19 Epilepsy. Neuron. 2018;97:59–66 e55. doi: 10.1016/j.neuron.2017.12.005.
    1. Camacho A, Simón R, Sanz R, Viñuela A, Martínez-Salio A, Mateos F. Cognitive and behavioral profile in females with epilepsy with PDCH19 mutation: two novel mutations and review of the literature. Epilepsy Behav. 2012;24:134–7. doi: 10.1016/j.yebeh.2012.02.023.
    1. Hayashi S, Inoue Y, Hattori S, Kaneko M, Shioi G, Miyakawa T, et al. Loss of X-linked Protocadherin-19 differentially affects the behavior of heterozygous female and hemizygous male mice. Sci Rep. 2017;7:5801. doi: 10.1038/s41598-017-06374-x.
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th edn. Washington: American Psychiatric Publishing; 2013.
    1. Kaptein S, Jansen D, Vogels A, Reijneveld S. Mental health problems in children with intellectual disability: use of the strengths and difficulties questionnaire. J Intellect Disabil Res. 2008;52:125–31.
    1. Cappelletti S, Specchio N, Moavero R, Terracciano A, Trivisano M, Pontrelli G, et al. Cognitive development in females with PCDH19 gene-related epilepsy. Epilepsy Behav. 2015;42:36–40. doi: 10.1016/j.yebeh.2014.10.019.
    1. Hynes K, Tarpey P, Dibbens LM, Bayly MA, Berkovic SF, Smith R, et al. Epilepsy and mental retardation limited to females with PCDH19 mutations can present de novo or in single generation families. J Med Genet. 2010;47:211–6. doi: 10.1136/jmg.2009.068817.
    1. Dawson G, Rogers S, Munson J, Smith M, Winter J, Greenson J, et al. Randomized, controlled trial of an intervention for toddlers with autism: the early start Denver model. Pediatrics. 2010;125:e17–e23. doi: 10.1542/peds.2009-0958.
    1. Eldevik S, Jahr E, Eikeseth S, Hastings RP, Hughes CJ. Cognitive and adaptive behavior outcomes of behavioral intervention for young children with intellectual disability. Behav Modif. 2010;34:16–34. doi: 10.1177/0145445509351961.
    1. Jones K, Daley D, Hutchings J, Bywater T, Eames C. Efficacy of the Incredible Years Programme as an early intervention for children with conduct problems and ADHD: long‐term follow‐up. Child Care Health Dev. 2008;34:380–90. doi: 10.1111/j.1365-2214.2008.00817.x.
    1. Marini C, Darra F, Specchio N, Mei D, Terracciano A, Parmeggiani L, et al. Focal seizures with affective symptoms are a major feature of PCDH19 gene–related epilepsy. Epilepsia. 2012;53:2111–9. doi: 10.1111/j.1528-1167.2012.03649.x.
    1. Higurashi N, Shi X, Yasumoto S, Oguni H, Sakauchi M, Itomi K, et al. PCDH19 mutation in Japanese females with epilepsy. Epilepsy Res. 2012;99:28–37. doi: 10.1016/j.eplepsyres.2011.10.014.
    1. Kwong AKY, Fung CW, Chan SY, Wong VCN. Identification of SCN1A and PCDH19 mutations in Chinese children with Dravet syndrome. PLoS ONE. 2012;7:e41802. doi: 10.1371/journal.pone.0041802.
    1. Higurashi N, Nakamura M, Sugai M, Ohfu M, Sakauchi M, Sugawara Y, et al. PCDH19-related female-limited epilepsy: further details regarding early clinical features and therapeutic efficacy. Epilepsy Res. 2013;106:191–9. doi: 10.1016/j.eplepsyres.2013.04.005.
    1. Fabisiak K, Erickson RP. A familial form of convulsive disorder with or without mental retardation limited to females: extension of a pedigree limits possible genetic mechanisms. Clin Genet. 1990;38:353–8. doi: 10.1111/j.1399-0004.1990.tb03594.x.
    1. Gokben S, Onay H, Yilmaz S, Atik T, Serdaroglu G, Tekin H, et al. Targeted next generation sequencing: the diagnostic value in early-onset epileptic encephalopathy. Acta Neurol Belg. 2016;117:1–8.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel